[The release of growth hormone in response to injection of trihexiphenidyl in patients with Alzheimer's disease, multi infarction dementia and in schizophrenic patients with intact cognitive functions (preliminary results)].
Salganik
I
I
D000368:Aged; D000544:Alzheimer Disease / Q000175:diagnosis*; D001921:Brain / Q000187:drug effects*; D018680:Cholinergic Antagonists / Q000494:pharmacology*; D003071:Cognition / Q000187:drug effects* / Q000502:physiology*; D015161:Dementia, Multi-Infarct / Q000175:diagnosis*; D003937:Diagnosis, Differential; D005260:Female; D019382:Human Growth Hormone / Q000096:biosynthesis*; D006801:Humans; D008297:Male; D012559:Schizophrenia / Q000175:diagnosis*; D014282:Trihexyphenidyl / Q000494:pharmacology*
D018680:Cholinergic Antagonists; D019382:Human Growth Hormone; D014282:Trihexyphenidyl